{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:04:18Z","timestamp":1791770658343,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clml.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T20:32:10Z","timestamp":1528835530000},"page":"e345-e350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of Monoclonal Gammopathy of Undetermined Significance in India\u2014A Hospital-based Study"],"prefix":"10.1016","volume":"18","author":[{"given":"Ritu","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meetu","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmy","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om Dutt","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.06.005_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2018.06.005_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clml.2013.12.010","article-title":"Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from Nagasaki atomic bomb survivors","volume":"14","author":"Iwanaga","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2018.06.005_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.005_bib4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2018.06.005_bib5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City","volume":"82","author":"Iwanaga","year":"2007","journal-title":"Japan Mayo Clin Proc"},{"key":"10.1016\/j.clml.2018.06.005_bib6","first-page":"91","article-title":"Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese","volume":"101","author":"Lee","year":"2002","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.clml.2018.06.005_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12185-011-0995-4","article-title":"Prevalence of monoclonal gammopathy of undetermined significance in Thailand","volume":"95","author":"Watanaboonyongcharoen","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2018.06.005_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2018.06.005_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/leu.2011.368","article-title":"Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites","volume":"26","author":"Greenberg","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.06.005_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A\u00a0long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2018.06.005_bib11","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.005_bib12","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A\u00a0monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.005_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2018.06.005_bib14","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population based study","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.005_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2018.06.005_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.clml.2018.06.005_bib17","first-page":"80","article-title":"Recent advances in the management of multiple myeloma","volume":"19","author":"Kumar","year":"2006","journal-title":"Natl Med J India"},{"key":"10.1016\/j.clml.2018.06.005_bib18","first-page":"192","article-title":"Autologous stem cell transplantation for multiple myeloma: long-term results","volume":"29","author":"Kumar","year":"2016","journal-title":"Natl Med J India"},{"key":"10.1016\/j.clml.2018.06.005_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000450881","article-title":"Prevalence of monoclonal gammopathy of undetermined significance in an apparently healthy Yixing population in mainland China","volume":"137","author":"Li","year":"2017","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2018.06.005_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00277-011-1293-1","article-title":"Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany","volume":"91","author":"Eisile","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2018.06.005_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1515\/CCLM.2007.029","article-title":"Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series","volume":"45","author":"Bergon","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clml.2018.06.005_bib22","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","article-title":"Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.005_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1445-5994.1971.tb02551.x","article-title":"The significance of monoclonal gammopathy in a normal population","volume":"4","author":"Carrell","year":"1971","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.clml.2018.06.005_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jamaoncol.2015.23","article-title":"The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma","volume":"1","author":"Sigurdardottir","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2018.06.005_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clml.2014.09.004","article-title":"Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER\u2013Medicare population analysis","volume":"15","author":"Go","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2018.06.005_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.06.005_bib27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2013.100552","article-title":"The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network","volume":"99","author":"van de Donk","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2018.06.005_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2018.06.005_bib29","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"P\u00e9rez-Persona","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.005_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ejh.12172","article-title":"Monoclonal gammopathy of undetermined significance: a new proposal of workup","volume":"91","author":"Mangiacavalli","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2018.06.005_bib31","unstructured":"Shukla NK, Julka PK, Manoharan N, Rath GK. Cancer incidence and mortality in Delhi UT Urban, 2011 and 2012. Delhi Cancer Registry, Dr. B.R.A. Ambedkar Institute Rotary Cancer Hospital, AIIMS, New Delhi; 2016."},{"key":"10.1016\/j.clml.2018.06.005_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamaoncol.2015.2938","article-title":"Agent Orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand veteran cohort study","volume":"1","author":"Landgren","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2018.06.005_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijheh.2013.04.006","article-title":"Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update","volume":"217","author":"Ruder","year":"2014","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.clml.2018.06.005_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamaoncol.2018.0509","article-title":"Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster","volume":"4","author":"Landgren","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018300284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018300284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:30:41Z","timestamp":1761870641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018300284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2152265018300284"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.06.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Monoclonal Gammopathy of Undetermined Significance in India\u2014A Hospital-based Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}